Anti-cancer responses to cytotoxic chemotherapies are critically dependent on wild-type TP53, as the activation of p53 by chemotherapy-induced DNA damage induces apoptosis and cancer cell death [22,23]. The gene discussed is TP53; the disease is cancer.